BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 35426495)

  • 1. Enhanced ion mobility resolution of Abeta isomers from human brain using high-resolution demultiplexing software.
    Mukherjee S; Fjeldsted JC; Masters CL; Roberts BR
    Anal Bioanal Chem; 2022 Jul; 414(18):5683-5693. PubMed ID: 35426495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of Isomeric Mixtures in Ion Mobility Using a Combined Demultiplexing and Peak Deconvolution Technique.
    May JC; Knochenmuss R; Fjeldsted JC; McLean JA
    Anal Chem; 2020 Jul; 92(14):9482-9492. PubMed ID: 32628451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Dynamics of β-Amyloid Proteoforms Accumulation in the Brain of a 5xFAD Mouse Model of Alzheimer's Disease.
    Bugrova AE; Strelnikova PA; Indeykina MI; Kononikhin AS; Zakharova NV; Brzhozovskiy AG; Barykin EP; Pekov SI; Gavrish MS; Babaev AA; Kosyreva AM; Morozova AY; Degterev DA; Mitkevich VA; Popov IA; Makarov AA; Nikolaev EN
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Resolution Demultiplexing (HRdm) Ion Mobility Spectrometry-Mass Spectrometry for Aspartic and Isoaspartic Acid Determination and Screening.
    Butler KE; Dodds JN; Flick T; Campuzano IDG; Baker ES
    Anal Chem; 2022 Apr; 94(16):6191-6199. PubMed ID: 35421308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Site-specific aspartic acid isomerization regulates self-assembly and neurotoxicity of amyloid-β.
    Sugiki T; Utsunomiya-Tate N
    Biochem Biophys Res Commun; 2013 Nov; 441(2):493-8. PubMed ID: 24383085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
    Michno W; Nyström S; Wehrli P; Lashley T; Brinkmalm G; Guerard L; Syvänen S; Sehlin D; Kaya I; Brinet D; Nilsson KPR; Hammarström P; Blennow K; Zetterberg H; Hanrieder J
    J Biol Chem; 2019 Apr; 294(17):6719-6732. PubMed ID: 30814252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease.
    Zampar S; Klafki HW; Sritharen K; Bayer TA; Wiltfang J; Rostagno A; Ghiso J; Miles LA; Wirths O
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):673-685. PubMed ID: 32497293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-truncated Aβ
    Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
    Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aspartic and isoaspartic acid residues in amyloid beta peptides, including Abeta1-42, using electron-ion reactions.
    Sargaeva NP; Lin C; O'Connor PB
    Anal Chem; 2009 Dec; 81(23):9778-86. PubMed ID: 19873993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody binding of amyloid beta peptide epimers/isomers and ramifications for immunotherapies and drug development.
    Readel ER; Patel A; Putman JI; Du S; Armstrong DW
    Sci Rep; 2023 Jul; 13(1):12387. PubMed ID: 37524807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-truncated Abeta starting with position four: early intraneuronal accumulation and rescue of toxicity using NT4X-167, a novel monoclonal antibody.
    Antonios G; Saiepour N; Bouter Y; Richard BC; Paetau A; Verkkoniemi-Ahola A; Lannfelt L; Ingelsson M; Kovacs GG; Pillot T; Wirths O; Bayer TA
    Acta Neuropathol Commun; 2013 Sep; 1():56. PubMed ID: 24252153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
    Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
    Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct deposition of amyloid-β species in brains with Alzheimer's disease pathology visualized with MALDI imaging mass spectrometry.
    Kakuda N; Miyasaka T; Iwasaki N; Nirasawa T; Wada-Kakuda S; Takahashi-Fujigasaki J; Murayama S; Ihara Y; Ikegawa M
    Acta Neuropathol Commun; 2017 Oct; 5(1):73. PubMed ID: 29037261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer's pathophysiology.
    Rostagno A; Cabrera E; Lashley T; Ghiso J
    Transl Neurodegener; 2022 Jun; 11(1):30. PubMed ID: 35641972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 μm Reveals Spatial Lipid and Peptide Correlates Implicated in Aβ Plaque Pathology in Alzheimer's Disease.
    Kaya I; Brinet D; Michno W; Başkurt M; Zetterberg H; Blenow K; Hanrieder J
    ACS Chem Neurosci; 2017 Dec; 8(12):2778-2790. PubMed ID: 28925253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
    Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
    J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metalloprotease ADAMTS4 generates N-truncated Aβ4-x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer's disease.
    Walter S; Jumpertz T; Hüttenrauch M; Ogorek I; Gerber H; Storck SE; Zampar S; Dimitrov M; Lehmann S; Lepka K; Berndt C; Wiltfang J; Becker-Pauly C; Beher D; Pietrzik CU; Fraering PC; Wirths O; Weggen S
    Acta Neuropathol; 2019 Feb; 137(2):239-257. PubMed ID: 30426203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of peptides that specifically bind Abeta1-40 amyloid in vitro and amyloid plaques in Alzheimer's disease brain using phage display.
    Kang CK; Jayasinha V; Martin PT
    Neurobiol Dis; 2003 Oct; 14(1):146-56. PubMed ID: 13678675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
    Kaya I; Zetterberg H; Blennow K; Hanrieder J
    ACS Chem Neurosci; 2018 Jul; 9(7):1802-1817. PubMed ID: 29648443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical imaging of evolving amyloid plaque pathology and associated Aβ peptide aggregation in a transgenic mouse model of Alzheimer's disease.
    Michno W; Wehrli P; Meier SR; Sehlin D; Syvänen S; Zetterberg H; Blennow K; Hanrieder J
    J Neurochem; 2020 Mar; 152(5):602-616. PubMed ID: 31605538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.